Literature DB >> 4248912

Blood levels and production rate of 17-hydroxypregnenolone in man.

C A Strott, J A Bermudez, M B Lipsett.   

Abstract

A reliable radio-ligand assay has been developed for the measurement of 17-hydroxypregnenolone in human peripheral vein plasma. The mean plasma concentration of 17-hydroxypregnenolone was, in men, 1.9 mmug/ml; and in women, 3.5 mmug/ml. These means were not significantly different from each other, and the levels were the same in the follicular and luteal phases of the menstrual cycle. In women, the adrenal cortex was the source of the 17-hydroxypregnenolone; in men, 40% was produced by the testis. Since the metabolic clearance rate was about 2000 liters/24 hr production rate estimates were 4-7 mg/24 hr. The conversion of blood 17-hydroxypregnenolone to blood 17-hydroxyprogesterone and dehydroepiandrosterone was measured. This varied from 5 to 20%. Thus, in women during the follicular phase, 17-hydroxyprogesterone derived from blood 17-hydroxypregnenolone could be the major fraction of the 17-hydroxyprogesterone production rate. Blood 17-hydroxypregnenolone is a minor precursor of blood dehydroepiandrosterone.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4248912      PMCID: PMC535778          DOI: 10.1172/JCI106420

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Induction and purification of alpha- and beta-hydroxysteroid dehydrogenases.

Authors:  P I MARCUS; P TALALAY
Journal:  J Biol Chem       Date:  1956-02       Impact factor: 5.157

2.  Further evidence of altered adrenocortical function in hypertension. Dehydroepiandrosterone excretion rate.

Authors:  W Nowaczynski; F Fragachan; J Silah; B Millette; J Genest
Journal:  Can J Biochem       Date:  1968-09

3.  In vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone in man.

Authors:  R Horton; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

4.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

5.  Gas chromatographic estimation of urinary delta-5-pregnene-3-beta, 17-alpha, 20-alpha-triol.

Authors:  K Kinoshita; K Isurugi; Y Matsumoto; H Takayasu
Journal:  Steroids       Date:  1968-01       Impact factor: 2.668

6.  Measurement of 17-hydroxyprogesterone in human plasma.

Authors:  C A Strott; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1968-10       Impact factor: 5.958

7.  Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.

Authors:  C A Strott; T Yoshimi; C W Bardin; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

8.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

9.  Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.

Authors:  C A Strott; T Yoshimi; M B Lipsett
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

10.  Metabolism of 17 alpha-hydroxypregnenolone-7 alpha-3H and 17 alpha-hydroxyprogesterone-4-14C in young and elderly men.

Authors:  L P Romanoff; K K Malhotra; M N Baxter; A W Thomas; G Pincus
Journal:  J Clin Endocrinol Metab       Date:  1968-06       Impact factor: 5.958

View more
  2 in total

1.  Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.

Authors:  G Schneider; M Genel; A M Bongiovanni; A S Goldman; R L Rosenfield
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

2.  Serum 21-deoxycortisol and 17-hydroxypregnenolone in parents of patients with congenital adrenal hyperplasia.

Authors:  F Cassorla; A Tenore; J S Parks; J Marino; A M Bongiovanni
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.